Artificial Intelligence has suddenly gone from the fringes of science to being everywhere. So how did we get here? And where's this all heading? In this new series of Science Friction, we're finding out.
…
continue reading
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!
Siirry offline-tilaan Player FM avulla!
Will ranitidine ever make a comeback?
MP3•Jakson koti
Manage episode 323237389 series 3329558
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Stomach acid-suppressing medicine ranitidine disappeared from pharmacy shelves two years ago, owing to fears of contamination with probable human carcinogen N-nitrosodimethylamine (NDMA). In this episode, features editor Dawn Connelly finds out why. She speaks with David Light, chief executive officer of Valisure, the online pharmacy that first identified the contamination in ranitidine, and Michael White, professor of pharmacy practice at the University of Connecticut, about the implications for other similar medicines. Connelly also assesses evidence ranitidine could be about to make a comeback and discusses the problems of switching to alternative treatments with Mikin Patel, lead pharmacist in gastroenterology at Imperial College Healthcare NHS Trust, London, and Alisdair Jones, a primary care network pharmacist in Folkestone, Kent. This episode was produced by Geoff Marsh and additional research was carried out by Emma Wilkinson.
…
continue reading
48 jaksoa
MP3•Jakson koti
Manage episode 323237389 series 3329558
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Stomach acid-suppressing medicine ranitidine disappeared from pharmacy shelves two years ago, owing to fears of contamination with probable human carcinogen N-nitrosodimethylamine (NDMA). In this episode, features editor Dawn Connelly finds out why. She speaks with David Light, chief executive officer of Valisure, the online pharmacy that first identified the contamination in ranitidine, and Michael White, professor of pharmacy practice at the University of Connecticut, about the implications for other similar medicines. Connelly also assesses evidence ranitidine could be about to make a comeback and discusses the problems of switching to alternative treatments with Mikin Patel, lead pharmacist in gastroenterology at Imperial College Healthcare NHS Trust, London, and Alisdair Jones, a primary care network pharmacist in Folkestone, Kent. This episode was produced by Geoff Marsh and additional research was carried out by Emma Wilkinson.
…
continue reading
48 jaksoa
Semua episod
×Tervetuloa Player FM:n!
Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.